Page 494 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 494

Chapter 30  Aplastic Anemia  414.e1

            REFERENCES                                            16.  Bacigalupo A: Bone marrow transplantation for acquired severe aplastic
                                                                     anemia. Hematol Oncol Clin North Am 28:1145–1155, 2014.
             1.  Scheinberg P, Young NS: How I treat aplastic anemia. Blood 120:1185,   17.  Schrezenmeier H, Passweg JR, Marsh JCW, et al: Worse outcome and
               2012.                                                 more chronic GVHD with peripheral blood progenitor cells than bone
             2.  Kaufman DW, Kelly JP, Levy M, et al: The drug etiology of agranulocytosis   marrow in HLA-matched sibling donor tranplants for young patients
               and aplastic anemia, New York, 1991, Oxford.          with severe aplastic anemia. Blood 110:1397–1400, 2007.
             3.  Issaragrisil  S,  Kaufman  D,  Anderson  T,  et al:  The  epidemiology  of   18.  Locasciulli A, Oneto R, Bacigalupo A, et al: Outcome of patients with
               aplastic anemia in Thailand. Blood 107:1299–1307, 2006.  acquired aplastic anemia given first line bone marrow transplantation or
             4.  Townsley DM, Dumitriu B, Young NS: Bone marrow failure and the   immunosuppressive treatment in the last decade: a report from the Euro-
               telomeropathies. Blood 124:2775–2783, 2014.           pean  Group  for  Blood  and  Marrow  Transplantation.  Haematologica
             5.  Dokal I, Vulliamy T: Inherited aplastic anaemias/bone marrow failure   92:11–18, 2007.
               syndromes. Blood Rev 40:719–722, 2008.             19.  Bacigalupo A, Socie G, Hamladji RM, et al: Current outcome of HLA
             6.  Maciejewski  JP,  Selleri  C, Tadatsugu  S,  et al:  A  severe  and  consistent   identical sibling vs. unrelated donor transplants in severe aplastic anemia:
               deficit  in  marrow  and  circulating  primitive  hematopoietic  cells   an EBMT analysis. Haematologica 100:696–702, 2015.
               (long-term  culture-initiating  cells)  in  acquired  aplastic  anemia.  Blood   20.  Horowitz MM: Current status of allogeneic bone marrow transplanta-
               88:1983–1991, 1996.                                   tion in acquired aplastic anemia. Semin Hematol 37:30–42, 2000.
             7.  Scheinberg P, Chen J: Aplastic anemia: what have we learned from animal   21.  Passweg JR, Marsh JC: Aplastic anemia: first-line treatment by immu-
               models and from the clinic. Semin Hematol 50:156–164, 2013.  nosuppression and sibling marrow transplantation. Hematology Am Soc
             8.  Kopolovic I, Ostro J, Tsubota H, et al: A systematic review of transfusion-  Hematol Educ Program 2010:36–42, 2010.
               associated graft-versus-host disease. Blood 126:406–414, 2015.  22.  Aderka D, Praff G, Santo M, et al: Bleeding due to thrombocytopenia in
             9.  Brown  KE, Tisdale  J,  Dunbar  CE,  et al:  Hepatitis-associated  aplastic   acute leukemias and reevaluation of the prophylactic platelet transfusion
               anemia. N Engl J Med 336:1059–1064, 1997.             policy. Am J Med Sci 291:147–151, 1986.
            10.  Afable  MG,  Wlodarski  M,  Makishima  H,  et al:  SNP  array-based   23.  de Peffault LR, Purtill D, Ruggeri A, et al: Influence of nucleated cell
               karyotyping:  differences  and  similarities  between  aplastic  anemia  and   dose  on  overall  survival  of  unrelated  cord  blood  transplantation  for
               hypocellular myelodysplastic syndromes. Blood 117:6876–6884, 2011.  patients with severe acquired aplastic anemia: a study by eurocord and
            11.  Yoshizato T, Dumitriu  B,  Hosokawa K,  et al:  Somatic  mutations  and   the aplastic anemia working party of the European group for blood and
               clonal hematopoiesis in aplastic anemia. N Engl J Med 373:35–47, 2014.  marrow transplantation. Biol Blood Marrow Transplant 17:78–85, 2011.
            12.  Valdez  JM,  Scheinberg  P,  Nunez  O,  et al:  Decreased  infection-related   24.  Sanders  JE,  Woolfrey  AE,  Carpenter  PA,  et al:  Late  effects  among
               mortality  and  improved  survival  in  severe  aplastic  anemia  in  the  past   pediatric patients followed for nearly 4 decades after transplantation for
               two decades. Clin Infect Dis 52:726–735, 2011.        severe aplastic anemia. Blood 118:1421–1428, 2011.
            13.  Leitman  SF,  Oblitas  JM,  Emmons  R,  et al:  Clinical  efficacy  of  daily   25.  Scheinberg P, Nunez O, Weinstein B, et al: Horse versus rabbit antithy-
               G-CSF-recruited granulocyte transfusions in patients with severe neutro-  mocyte globulin in acquired aplastic anemia. N Engl J Med 365:430–438,
               penia and life-threatening infections [abstract]. Blood 88(Suppl 1):331a,   2011.
               1996.                                              26.  Scheinberg  P,  Cooper  JN,  Sloand  EM,  et al:  Association  of  telomere
            14.  Tichelli A, Passweg JR: Matched sibling donor hematopoietic stem cell   length  of  peripheral  blood  leukocytes  predicts  hematopoietic  relapse,
               transplant in patients with acquired aplastic anemia. Curr Drug Targets   malignant transformation, and survival in severe aplastic anemia. JAMA
               2016. in press.                                       304:1358–1364, 2010.
            15.  Miano M, Dufour C: The diagnosis and treatment of aplastic anemia: a   27.  Townsley  DM,  Bogdan  D,  Delong  L,  et  al:  Danazol  treatment  for
               review. Int J Hematol 101:527–535, 2015.              telomere diseases. N Engl J Med 374:1922–1931, 2016.
   489   490   491   492   493   494   495   496   497   498   499